BNP Paribas Discount Zert MRNA 27.../ DE000PZ0UK93 /
2024-05-31 9:40:15 PM | Chg.-0.060 | Bid9:51:53 PM | Ask9:51:53 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
59.690EUR | -0.10% | 59.660 Bid Size: 3,300 |
59.710 Ask Size: 3,300 |
Moderna Inc | - USD | 2024-06-27 | Call |
GlobeNewswire
05-22
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
05-12
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
05-08
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-08
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
05-02
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-01
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire
05-01
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire
04-04
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...